A Study of Ipatasertib in Combination With Paclitaxel as a Treatment for Participants With PIK3CA/AKT1/PTEN-Altered, Locally Advanced or Metastatic, Triple-Negative Breast Cancer or Hormone Receptor-Positive, HER2-Negative Breast Cancer
Clinical trial NCT03337724 · COMPLETED
Trial details
- NCT number
- NCT03337724
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-06
- Primary completion
- 2023-01-04
- Enrollment
- 579
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.